Clinical Trial Update: An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

View source ↗

Summary

A completed epidemiological study sponsored by GlaxoSmithKline evaluating the performance of healthcare tools to understand HSV-2 genital infection in adults in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes

Snippet

Sponsor: GlaxoSmithKline | Conditions: Herpes Genitalis | Status: COMPLETED